BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maruschke M, Anastasiadis AG, Hakenberg OW. Spontaneous regression of renal cell carcinoma: Reality or myth? World J Clin Urol 2014; 3(3): 201-208 [DOI: 10.5410/wjcu.v3.i3.201]
URL: https://www.wjgnet.com/2219-2816/full/v3/i3/201.htm
Number Citing Articles
1
Alessia Stanzi, Elena Verzoni, Margherita Ruggirello, Luigi Rolli, Ugo Pastorino. Post-surgical Regression of Thoracic Metastases After Salvage Lobectomy for Recurrent Renal Cell CarcinomaClinical Genitourinary Cancer 2020; 18(3): e284 doi: 10.1016/j.clgc.2019.11.021
2
Lisa BE Shields, Arash Rezazadeh Kalebasty. Metastatic clear cell renal cell carcinoma in isolated retroperitoneal lymph node without evidence of primary tumor in kidneys: A case reportWorld Journal of Clinical Oncology 2020; 11(2): 103-109 doi: 10.5306/wjco.v11.i2.103
3
Isao Otsuka. Primary Retroperitoneal Carcinomas: New Insights into Pathogenesis and Clinical Management in Comparison with Ovarian Carcinomas and Carcinoma of Unknown PrimaryCancers 2023; 15(18): 4614 doi: 10.3390/cancers15184614
4
David A. Braun, Ziad Bakouny, Laure Hirsch, Ronan Flippot, Eliezer M. Van Allen, Catherine J. Wu, Toni K. Choueiri. Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaNature Reviews Clinical Oncology 2021; 18(4): 199 doi: 10.1038/s41571-020-00455-z
5
Alwalid Freih-Fraih, Guillermo Celada-Luis, Tamara Ranchal, Claudio Lagana, Alberto Canca-Velasco, José A. Jiménez-Heffernan. Complete spontaneous regression of a primary renal cell carcinoma. Report of a pathological proven case and review of the literatureRevista Española de Patología 2022; 55: S69 doi: 10.1016/j.patol.2019.09.002
6
Lisa B.E. Shields, Arash Rezazadeh Kalebasty. Spontaneous Regression of Delayed Pulmonary and Mediastinal Metastases from Clear Cell Renal Cell CarcinomaCase Reports in Oncology 2020; 13(3): 1285 doi: 10.1159/000509509
7
Kay McGillivray, Roisin McKenna, Grenville Oades, Flora Rodger. Spontaneous regression of metastatic renal cancer and improvement in IMDC risk criteria prior to cytoreductive nephrectomyUrology Case Reports 2023; 51: 102561 doi: 10.1016/j.eucr.2023.102561